Royal Bank of Canada
IMCR icon

Royal Bank of Canada’s Immunocore IMCR Stock Holding History

Royal Bank of Canada’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
44,714
+2,228
+5% +$72.1K ﹤0.01% 3399
2025
Q4 		$1.48M Sell
42,486
-3,171
-7% -$112K ﹤0.01% 3353
2025
Q3 		$1.66M Sell
45,657
-909
-2% -$30.9K ﹤0.01% 3562
2025
Q2 		$1.46M Buy
46,566
+2,555
+6% +$79.4K ﹤0.01% 3568
2025
Q1 		$1.31M Buy
44,011
+13,689
+45% +$411K ﹤0.01% 3265
2024
Q4 		$895K Sell
30,322
-14,648
-33% -$463K ﹤0.01% 3635
2024
Q3 		$1.4M Buy
44,970
+515
+1% +$18.7K ﹤0.01% 3266
2024
Q2 		$1.51M Buy
44,455
+2,158
+5% +$110K ﹤0.01% 3121
2024
Q1 		$2.75M Buy
42,297
+73
+0.2% +$5.01K ﹤0.01% 2665
2023
Q4 		$2.88M Buy
42,224
+8,967
+27% +$466K ﹤0.01% 2731
2023
Q3 		$1.73M Buy
33,257
+9,521
+40% +$563K ﹤0.01% 2977
2023
Q2 		$1.42M Buy
23,736
+23,705
+76,468% +$1.35M ﹤0.01% 3110
2023
Q1 		$2K Buy
31
+22
+244% +$1.24K ﹤0.01% 6773
2022
Q4 		$1K Sell
9
-249
-97% -$14K ﹤0.01% 7039
2022
Q3 		$12K Sell
258
-2,400
-90% -$114K ﹤0.01% 6350
2022
Q2 		$99K Hold
2,658
– – ﹤0.01% 5335
2022
Q1 		$79K Buy
+2,658
New +$67.1K ﹤0.01% 5807

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Royal Bank of Canada's IMCR Position: Q1 2026 in Review

Royal Bank of Canada increased its Immunocore (IMCR) stake by 5.2% in Q1 2026, buying an estimated $72.1K and bringing the position to 44,714 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

Royal Bank of Canada first reported a position in IMCR in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.88M in Q4 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Royal Bank of Canada held 44,714 shares of Immunocore worth $1.35M as of Q1 2026.
  • Royal Bank of Canada bought 2,228 Immunocore shares in Q1 2026, an estimated $72.1K.
  • Immunocore made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3399 holding.
  • Royal Bank of Canada first reported a position in Immunocore in Q1 2022 and has held it in 17 quarters since.
  • Royal Bank of Canada's Immunocore position peaked at $2.88M in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.